Carl‐Henrik Heldin
- Molecular Biology top 0.01%
- Oncology top 0.05%
- Cancer Research top 0.05%
- Cell Biology top 0.05%
- Immunology top 0.2%
- Co-authors
- Bengt WestermarkAristidis MoustakasPeter ten DijkeKohei MiyazonoLena Claesson‐WelshÅke WastesonArne ÖstmanKristian Pietras
- Topics
- TGF-β signaling in diseases (150 papers)Cell Adhesion Molecules Research (70 papers)Protein Kinase Regulation and GTPase Signaling (54 papers)
In The Last Decade
Carl‐Henrik Heldin
492 papers receiving 61.0k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Molecular Biology 41.7k
- Oncology 14.1k
- Cancer Research 8.9k
- Cell Biology 6.7k
- Immunology 5.9k
Countries citing papers authored by Carl‐Henrik Heldin
This map shows the geographic impact of Carl‐Henrik Heldin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl‐Henrik Heldin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl‐Henrik Heldin more than expected).
Fields of papers citing papers by Carl‐Henrik Heldin
This network shows the impact of papers produced by Carl‐Henrik Heldin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl‐Henrik Heldin. The network helps show where Carl‐Henrik Heldin may publish in the future.
Co-authorship network of co-authors of Carl‐Henrik Heldin
This figure shows the co-authorship network connecting the top 25 collaborators of Carl‐Henrik Heldin. A scholar is included among the top collaborators of Carl‐Henrik Heldin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl‐Henrik Heldin. Carl‐Henrik Heldin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 9 | |
| 4 | 8 | |
| 5 | 9 | |
| 6 | 13 | |
| 7 | 8 | |
| 8 | 23 | |
| 9 | 8 | |
| 10 | 4 | |
| 11 | 18 | |
| 12 | 6 | |
| 13 | 66 | |
| 14 | 44 | |
| 15 | 23 | |
| 16 | 172 | |
| 17 | 62 | |
| 18 | 3 | |
| 19 | 107 | |
| 20 | 202 |
About Carl‐Henrik Heldin
Carl‐Henrik Heldin is a scholar working on Immunology and Allergy, Molecular Biology and Oncology, having authored 494 papers that have together received 62.7k indexed citations. Recurring topics across this work include TGF-β signaling in diseases (150 papers), Cell Adhesion Molecules Research (70 papers) and Protein Kinase Regulation and GTPase Signaling (54 papers). The work is most often cited by research in Immunology and Allergy (5.1k citations), Molecular Biology (41.7k citations) and Cancer Research (8.9k citations). Carl‐Henrik Heldin has collaborated with scholars based in Sweden, Belgium and Japan. Frequent co-authors include Bengt Westermark, Aristidis Moustakas, Peter ten Dijke, Kohei Miyazono, Lena Claesson‐Welsh, Åke Wasteson, Arne Östman, Kristian Pietras, Ulf Hellman and Kristofer Rubin. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.